Bioregulatory Medicine
Peptide Therapy
The targeted use of bioregulatory peptides to support tissue-specific repair, immune modulation, and cellular signaling pathways, administered under physician supervision as part of individualized treatment protocols.
What Is Peptide Therapy?
Peptides are short chains of amino acids that serve as signaling molecules in the body, regulating a wide range of physiological processes including immune function, tissue repair, inflammation, and cellular communication. Therapeutic peptides are designed to replicate or enhance these natural signaling functions.
At St. George Hospital, peptide therapy is used within the framework of European biological medicine. Specific peptides are selected based on the patient’s diagnosis and treatment goals, and are administered via injection or infusion under medical supervision. This therapy is considered an adjunct to primary treatment protocols rather than a standalone intervention.
Peptide Preparation Image
How Does It Work?
Bioregulatory peptides interact with specific receptors on target cells, triggering intracellular signaling cascades. Depending on the peptide used, these signals can promote tissue regeneration, modulate immune cell activity, reduce inflammatory mediator production, or support hormonal balance.
Examples include thymic peptides that support T-cell maturation and immune regulation, organ-specific peptides from European biological medicine traditions, and newer synthetic peptides with defined molecular targets. The choice of peptide, dose, and route of administration is determined by the attending physician based on the patient’s specific clinical needs.
Clinical Applications
Peptide therapy at St. George Hospital may be considered as a supportive treatment for:
- Immune dysregulation in chronic infections
- Tissue repair following injury or surgery
- Age-related hormonal and metabolic changes
- Chronic inflammatory conditions
- Post-infection immune reconstitution
Note: Peptide therapy is an evolving field. At St. George Hospital, peptides are used within established European medical frameworks. Specific therapeutic claims are not made beyond what is supported by the current level of evidence for each individual peptide.
Could this belong in your plan?
That depends on your findings, not on the therapy. Send what you have with a short history; a physician reads it before the video call and tells you whether this treatment belongs in your program.
What a session feels like
- Before Your physician explains the route: a small injection under the skin, or a slow intravenous infusion.
- During 15–30 minutes depending on route and protocol. An injection is over in seconds; an infusion is a quiet quarter-hour in a chair.
- Afterwards A red or tender spot at the injection site is possible. Course length varies widely with the indication and the peptides used.
Evidence & Safety
The evidence base for therapeutic peptides varies considerably by compound. Some peptides, such as thymosin alpha-1, have robust clinical trial data and regulatory approval in multiple countries. Others are supported primarily by preclinical research and case series. At St. George Hospital, peptide selection is guided by the available evidence and clinical experience. Safety monitoring includes regular laboratory assessments and clinical follow-up to evaluate both efficacy and tolerability.
Request a consultation
A video consultation in English before you travel. A physician reviews your findings first; we reply by email within one business day (Mon–Fri).
Mon–Thu 08:00–17:00, Fri 08:00–14:00 (CET/CEST)+49 8061 398-0info@clinicum-stgeorg.de
St. George Hospital is a specialist hospital, not an emergency department. In a medical emergency in Germany, dial 112.